This single-day program will consist of lectures and case discussions highlighting a multidisciplinary approach to the management of urologic disease with the integration of new technology in the evaluation and treatment of patients. Evidence-based medicine highlighting relevant clinical trial data will be provided as well as focusing on current controversies in prostate cancer, urologic malignancies, and the management of benign conditions.
Topics include the latest in adjuvant therapies, testosterone replacement, developments in imaging and staging for prostate cancer, risk stratification for NMIBC, novel treatments for upper tract tumors, postoperative incontinence, nephrolithiasis, neuro-urology, robotic surgery, and the management of intraoperative complications.
Date & Location
Friday, August 25th, 2023, 8:00 AM - 4:30 PM, Samis Education Center, 1200 Children's Ave, Oklahoma City, OK
Urologists, Primary Care Physicians, Specialty Physicians, Oncologists, Radiation Oncologists, Related Physician Assistants, Nurses, Nurse Practitioners, Navigators, and other Administrative Staff Supporting Oncology Programs.
- Describe the role of MRI, Micro-ultrasound, and PSMA PET imaging in clinical management of prostate cancer.
- Improve knowledge of medical and surgical management of nephrolithiasis.
- Improve knowledge of evolving concepts in the management of upper tract tumors.
Registration for Attendees - The registration fee is complimentary, but registration is required.
Exhibitors, please contact, Holly Weldon at email@example.com.
If you are not able to attend, please notify Holly Weldon at firstname.lastname@example.org to release your reservation for another attendee.
For more information or if you have questions, please contact Holly Weldon - at 405-271-2140 or email@example.com
Friday, August 25th | 6:30 AM - 3:15 PM
||BREAKFAST & EXHIBITS
||Introduction & Welcome
||Kelly Stratton, MD
||MRI and microultrasound to improve prostate cancer disease
||Andrew McIntosh, MD
||Next Generation Imaging and Prostate Cancer Theranostics
||Kelly Stratton, MD
||Panel Discussion: Prostate Cancer
||Moderator: Michael Cookson, MD
Panelists: David Cochran, MD, Jared Higley, MD, Mohammad Ramadan, MD
||Sam Chang, MD
||Intermediate Risk Bladder Cancer: Risk Stratification and Treatment Implications
||Sanjay Patel, MD
||Panel Discussion: Bladder Cancer
||Moderator: Sam Chang, MD
Panelists: Daniel Parker, MD, Brian Cross, MD, Sanjay Patel, MD
||Adjuvant Therapy for the General Urologist: What you need to know
||Daniel Parker, MD
||BREAK & EXHIBITS
||What's New in Invasive Bladder Cancer
||Adanma Ayanambakkam, MD
||Shared Decision Making in Prostate Cancer
||Jonathan Heinlen, MD
||Emergencies in Urolithiasis
||Julie Riley, MD
||LUNCH & EXHIBITS
| 1:00 PM
||Panel Discussion: Stones
||Moderator: Julie Riley, MD
Panelists: Gennady Slobodov, MD, Nathan Bradley, MD, James Wendelken, MD
||Testosterone replacement in Prostate Cancer Patients
||Johnathan Doolittle, MD
| 1:45 PM
||Male Incontinence Post-Prostatectomy
||James Furr, MD
| 2:00 PM
||Detrussor underactivity in the Setting of BPH
||Gennady Slobodov, MD
| 2:15 PM
||Managing Intraoperative Complications in Urologic Oncology
||Brian Cross, MD
| 2:30 PM
||Resident Case Presentations: Four 10 min presentations T-Leon Howard style, prize for winner
| 3:15 PM
The University of Oklahoma Health Science
2023 Oklahoma Urologic Symposium
August 25, 2023
Oklahoma City, OK
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and The University of Oklahoma Heath Science. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation #4008163.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 5.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP.
PAs may claim a maximum of 5.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.